The sgRNAs targeting regions reported to be important for the interaction with survivin and p14 and the region reported to bind PABP showed no loss of representation, suggesting that these regions are not critical for leukemia cell survival and are unlikely to be important for mediating the activity of drug-induced GSPT1 degradation. This evidence concerns the gene CDKN2A and leukemia.